The burgeoning landscape of innovative treatments for body management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a comparable https://gretafuik559936.wikievia.com/10974468/retatrutide_vs_tirzepatide_a_comparative_analysis